Global Rheumatoid Arthritis Market 2018 Key Players: Merck, Janssen Biologics B.V., Pfizer Limited, Amgen, Novartis, GSK, Celgene, Eli Lilly, Abbvie, Sanofi

Rheumatoid Arthritis Market:

WiseGuyReports.com adds “Rheumatoid Arthritis Market 2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting ”reports to its database.

Executive Summary

Adroit Healthcare Services Rheumatoid Arthritis - Competitive Landscape and Market, Market Access Potential, Pricing & Pipeline Analysis, 2018' provide the comprehensive research on the competitive landscape and therapies indicated for rheumatoid arthritis.

The report is built with the in-depth secondary research, understanding the market access aspects across the different countries. The main objective of this report is to provide a comprehensive secondary research and market analysis of different therapies indicated for rheumatoid arthritis including the market access and reimbursement challenges across EU5 and US.

The report includes in depth sales reports of different class of therapies, detailed mechanism of action, comprehensive clinical trial data, time line of important events, pricing and market access across the significant markets (EU3+US). This report also includes the pipeline analysis of filed, phase 3, phase 2, phase 1, preclinical products across the different classes.

This report also provides comprehensive research on the companies that are working on different class of drugs for rheumatoid arthritis including the deals and acquisitions (collaborations and merges).

Companies Mentioned

Merck, Janssen Biologics B.V., Pfizer Limited, Amgen, Novartis, GSK, Celgene, Eli Lilly, Abbvie, Sanofi

Request Sample Report @ https://www.wiseguyreports.com/sample-request/3096398-rheumatoid-arthritis-competitive-landscape-and-market-market-access

Table of Content

Disease Landscape

Etiology and Pathophysiology
Disease Overview
Key Pathways and Drug Targets
Market Overview

Therapeutic assessment by drug class

TNF-Alpha Inhibitors
B-Cell-Targeted Therapies
IL-6 Inhibitors
JAK Inhibitors
RANKL Inhibitors
Adenosine Receptor Agonists
Market Drivers and Constraints

Current Treatment Overview

Key Findings

Key Current Therapies

Humira & Biosimilars
Remicade & Biosimilars
Enbrel & Biosimilars
Simponi
Cimzia
Orencia
Olumiant
Rituxan/MabThera
Kineret
Kevzara
Biosimilars Drug profiling

GP2017/Sandoz
BI695501/Boehringer Ingelheim
PF-06410293/Pfizer
FKB327/Fujifilm Kyowa Kirin Biologics
MYL-1401A/Biocon/Mylan
CHS-1420/Coherus
M923/Momenta
ONS-3010/Oncobiologics/ Viropro
MSB11022/Fresenius
Unmet Need Overview

Pipeline Analysis

Late Stage Pipeline Analysis
Mid Stage Pipeline Analysis
Early Stage Pipeline Analysis
Discontinued Products
Access & Reimbursement Overview

United States
EU5
Continuous…

For further information on this report, visit – https://www.wiseguyreports.com/reports/3096398-rheumatoid-arthritis-competitive-landscape-and-market-market-access

Contact Us:

Norah Trent           

sales@wiseguyreports.com

Ph: +1-646-845-9349 (US); +44 208 133 9349 (UK)

About Us:
Wise Guy Reports Is Part Of The Wise Guy Consultants Pvt. Ltd. And Offers Premium Progressive Statistical Surveying, Market Research Reports, Analysis & Forecast Data For Industries And Governments Around The Globe. Wise Guy Reports Features An Exhaustive List Of Market Research Reports From Hundreds Of Publishers Worldwide. We Boast A Database Spanning Virtually Every Market Category And An Even More Comprehensive Collection Of Market Research Reports Under These Categories And Sub-Categories.

Addres:
WISEGUY RESEARCH CONSULTANTS PVT LTD
Office No. 528, Amanora Chambers
Pune - 411028
Maharashtra, India
Phone :+91 841 198 5042

This release was published on openPR.